GPs able to initiate FP 50 prescriptions again The revised listing follows a concerted advocacy campaign and was confirmed on the same day as a number of other PBS changes.
Drug ‘significantly’ slows Alzheimer’s progression: Study A clinical trial of donanemab has now been peer reviewed and published, indicating it can decelerate decline in the disease’s early stages.
New Alzheimer’s medication found to slow cognitive decline The drug may be available as early as 2023, but there are still hurdles to cross, write Bernadette McGuinness and Elizabeth Coulthard.